Anti-PKD1L3 antibodies are used in the immunodetection of the protein polycystin 1 like 3, transient receptor potential channel interacting. In humans, the canonical protein has a reported length of 1732 amino acid residues and a mass of 195.9 kDa. Its subcellular localization is in the cell membrane. It is reported to be highly expressed in the placenta, weakly in the heart and lung. A member of the Polycystin protein family, PKD1L3 is a known component of the calcium channel. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include PC1-like 3 protein, polycystic kidney disease 1-like 3, polycystin-1L3, and polycystic kidney disease protein 1-like 3. PKD1L3 gene orthologs have been reported in the mouse, rat, bovine, frog and chimpanzee species. Some PKD1L3 antibodies may have been used in research and have associated citations. Immunofluorescence is a widely used application for these antibodies. ELISA, Immunocytochemistry, and Immunohistochemistry are also common applications.